• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿维A对器官移植受者伤口愈合的影响。

Effect of acitretin on wound healing in organ transplant recipients.

作者信息

Tan Stephen R, Tope Whitney D

机构信息

Cutaneous Surgery and Laser Center, Department of Dermatology, University of Minnesota, USA.

出版信息

Dermatol Surg. 2004 Apr;30(4 Pt 2):667-73. doi: 10.1111/j.1524-4725.2004.00154.x.

DOI:10.1111/j.1524-4725.2004.00154.x
PMID:15061853
Abstract

BACKGROUND

Systemic retinoids possess significant benefits in cutaneous malignancy chemoprevention; however, retinoids have been associated with excessive granulation tissue and hypertrophic scarring.

OBJECTIVE

The objective of this study was to assess wound healing outcomes in organ transplant recipients, both with and without the concomitant use of systemic acitretin chemoprophylaxis.

METHODS

Twenty-nine immunosuppressed organ transplant recipients underwent treatment of basal cell or squamous cell carcinoma by Mohs or excisional surgery, with a total of 85 wounds. Wounds were evaluated postoperatively at early (average 12.9 days) and late (average 75.8 days) time points. Endpoints for all wounds included infection, hypertrophic granulation tissue, and hypertrophic scarring. Reconstructed wounds were also evaluated for dehiscence.

RESULTS

Eleven patients taking oral acitretin had 41 wounds, of which 33 were reconstructed and 8 healed by second intention. The 18 patients not taking acitretin (control group) had a total of 44 wounds, of which 33 were reconstructed and 11 healed by second intention. There were no statistically significant differences between the acitretin group and the control group in the incidences of infection, dehiscence, hypertrophic granulation tissue, or hypertrophic scarring at early or late evaluation points.

CONCLUSIONS

Systemic acitretin chemoprophylaxis does not appear to increase the risk of wound healing complications in organ transplant recipients.

摘要

背景

全身性维甲酸在皮肤恶性肿瘤化学预防方面具有显著益处;然而,维甲酸与过度肉芽组织形成和肥厚性瘢痕有关。

目的

本研究的目的是评估器官移植受者在使用和不使用全身性阿维A化学预防的情况下的伤口愈合结果。

方法

29名免疫抑制的器官移植受者通过莫氏手术或切除手术治疗基底细胞癌或鳞状细胞癌,共有85处伤口。在术后早期(平均12.9天)和晚期(平均75.8天)时间点对伤口进行评估。所有伤口的终点包括感染、肥厚性肉芽组织和肥厚性瘢痕。还对重建的伤口进行裂开评估。

结果

11名口服阿维A的患者有41处伤口,其中33处进行了重建,8处二期愈合。18名未服用阿维A的患者(对照组)共有44处伤口,其中33处进行了重建,11处二期愈合。在早期或晚期评估点,阿维A组和对照组在感染、裂开、肥厚性肉芽组织或肥厚性瘢痕的发生率方面没有统计学上的显著差异。

结论

全身性阿维A化学预防似乎不会增加器官移植受者伤口愈合并发症的风险。

相似文献

1
Effect of acitretin on wound healing in organ transplant recipients.阿维A对器官移植受者伤口愈合的影响。
Dermatol Surg. 2004 Apr;30(4 Pt 2):667-73. doi: 10.1111/j.1524-4725.2004.00154.x.
2
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.全身及局部使用维甲酸类药物治疗器官移植受者的皮肤癌
Dermatol Surg. 2004 Apr;30(4 Pt 2):656-61. doi: 10.1111/j.1524-4725.2004.30152.x.
3
Systemic retinoids: chemoprevention of skin cancer in transplant recipients.全身性维甲酸类药物:移植受者皮肤癌的化学预防
Skin Therapy Lett. 2010 Jul-Aug;15(7):1-4.
4
Systemic strategies for chemoprevention of skin cancers in transplant recipients.移植受者皮肤癌化学预防的全身策略。
Clin Transplant. 2005 Dec;19(6):726-34. doi: 10.1111/j.1399-0012.2005.00412.x.
5
Practical retinoid chemoprophylaxis in solid organ transplant recipients.实体器官移植受者的实用类维生素A化学预防
Dermatol Ther. 2005 Jan-Feb;18(1):28-33. doi: 10.1111/j.1529-8019.2005.05006.x.
6
The cuticular purse string suture: a modified purse string suture for the partial closure of round postoperative wounds.角质层荷包缝合术:一种用于术后圆形伤口部分闭合的改良荷包缝合术。
Int J Dermatol. 2007 Jul;46(7):746-53. doi: 10.1111/j.1365-4632.2007.03253.x.
7
Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma.系统性维甲酸治疗器官移植受者鳞状细胞癌的并发症。
Dermatol Surg. 2004 Apr;30(4 Pt 2):662-6. doi: 10.1111/j.1524-4725.2004.30153.x.
8
Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.低剂量维甲酸预防器官移植受者皮肤鳞状细胞癌:一项16年的回顾性研究。
Arch Dermatol. 2005 Apr;141(4):456-64. doi: 10.1001/archderm.141.4.456.
9
Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey.口服维甲酸用于器官移植受者皮肤癌的化学预防:一项调查结果
Transplant Proc. 2006 Jun;38(5):1366-8. doi: 10.1016/j.transproceed.2006.02.119.
10
Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.系统性类视黄醇用于高危患者非黑色素瘤皮肤癌的化学预防。
J Drugs Dermatol. 2010 Jul;9(7):753-8.

引用本文的文献

1
Use of oral retinoids in the perioperative period by surgical specialty: a literature review.按外科专业划分围手术期口服维甲酸类药物的使用:一项文献综述
Arch Dermatol Res. 2025 Jan 6;317(1):174. doi: 10.1007/s00403-024-03750-2.
2
Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky?切开手术期间口服异维甲酸(泰尔丝):安全还是有风险?
Case Reports Plast Surg Hand Surg. 2022 May 13;9(1):131-134. doi: 10.1080/23320885.2022.2071275. eCollection 2022.
3
Systemic Retinoids and Scar Dehiscence.全身性维甲酸与瘢痕裂开
Indian J Dermatol. 2019 Jan-Feb;64(1):68-70. doi: 10.4103/ijd.IJD_148_18.